“Bioeconomy, biotechnology, multi-million dollar business”, these are three phrases frequently talked during my stay at PAG earlier this year.
Since the internet revolution in 1990s, people are in dire need of a new technology revolution, which is supposed to change our life and work style.
When everyone focuses on AI and ChatGPT, gene editing technology suddenly takes on headline news. GMO crops are not something new, this time, we are confronted with gene engineering medicine!
- On December 8, 2023, FDA approved gene therapy for treatment of sickle cell disease.
- On Feb. 15, 2024, two RNA-editing therapies have gained approval for clinical trials.
As Nature news just reported, “a new wave of gene editors heads for clinical trials”. Without extensive public attention, gene editing medicine have entered in our lives.
As I am writing this blog, Nature news is reporting, “engineered immune cells enters US trials for first time”.
This is the first time in history, human bodies are “edited”. For good or for bad, era of gene-engineering medicine has come!